scispace - formally typeset
H

Hiroaki Shimokawa

Researcher at Tohoku University

Publications -  976
Citations -  56856

Hiroaki Shimokawa is an academic researcher from Tohoku University. The author has contributed to research in topics: Heart failure & Endothelium. The author has an hindex of 111, co-authored 949 publications receiving 48822 citations. Previous affiliations of Hiroaki Shimokawa include University of Nebraska Medical Center & Nagoya University.

Papers
More filters
Journal Article

Inhibition of Rho-kinase by fasudil prevents anginal attacks associated with spastic angina: A case report

TL;DR: This case suggests that a Rho-kinase inhibitor is potentially effective to prevent anginal attacks in spastic angina, and should be considered for use in elderly patients with unstable angina pectoris.
Journal ArticleDOI

Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.

TL;DR: Results indicate that the vascular Epo/EpoR system plays an important protective role against hypoxia/ischemia, demonstrating that this system is a novel therapeutic target in cardiovascular medicine.
Journal ArticleDOI

Prognostic Impact of Diabetes Mellitus in Chronic Heart Failure According to Presence of Ischemic Heart Disease – With Special Reference to Nephropathy –

TL;DR: The prognostic impact of DM was more evident in patients with IHD than in those without IHD, particularly when complicated with nephropathy, and when the patients were stratified by nephrostathy, DM was associated with worse prognosis only in the IHD patients with ne phropathy.
Journal ArticleDOI

Effects of nitric oxide synthase isoform deletion on oxytocin and vasopressin messenger RNA in mouse hypothalamus.

TL;DR: It is suggested that neuronal nitric-oxide-synthase-derived nitric oxide may be involved in the regulation of oxytocin gene expression in the anterior commissural nucleus of neuronal Nitric oxide synthase knockout mice.